ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis A Vaccine Market Research Report 2026
Published Date: 2026-01-16
|
Report Code: QYRE-Auto-22O67
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hepatitis A Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Hepatitis A Vaccine Market Research Report 2026

Code: QYRE-Auto-22O67
Report
2026-01-16
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Convac
KM Biologics
Imbcams

Hepatitis A Vaccine Market Size

The global Hepatitis A Vaccine market was valued at US$ 766 million in 2025 and is anticipated to reach US$ 892 million by 2032, at a CAGR of 2.2% from 2026 to 2032.

Hepatitis A Vaccine Market

Hepatitis A Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hepatitis A Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
This report delivers a comprehensive overview of the global Hepatitis A Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hepatitis A Vaccine. The Hepatitis A Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Unit) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hepatitis A Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hepatitis A Vaccine Market Report

Report Metric Details
Report Name Hepatitis A Vaccine Market
Accounted market size in 2025 US$ 766 million
Forecasted market size in 2032 US$ 892 million
CAGR 2.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Inactivated Vaccine
  • Live Attenuated Vaccine
by Application
  • Government Institution
  • Private Sector
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hepatitis A Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hepatitis A Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hepatitis A Vaccine Market growing?

Ans: The Hepatitis A Vaccine Market witnessing a CAGR of 2.2% during the forecast period 2026-2032.

What is the Hepatitis A Vaccine Market size in 2032?

Ans: The Hepatitis A Vaccine Market size in 2032 will be US$ 892 million.

What is the market share of major companies in Hepatitis A Vaccine Market?

Ans: Global top 5 manufacturers hold a share over 80%.

What is the Hepatitis A Vaccine Market share by type?

Ans: In terms of product, inactivated vaccine is the largest segment, with a share about 85%.

Who are the main players in the Hepatitis A Vaccine Market report?

Ans: The main players in the Hepatitis A Vaccine Market are GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac

What are the Application segmentation covered in the Hepatitis A Vaccine Market report?

Ans: The Applications covered in the Hepatitis A Vaccine Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Hepatitis A Vaccine Market report?

Ans: The Types covered in the Hepatitis A Vaccine Market report are Inactivated Vaccine, Live Attenuated Vaccine

1 Hepatitis A Vaccine Market Overview
1.1 Product Definition
1.2 Hepatitis A Vaccine by Type
1.2.1 Global Hepatitis A Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine by Application
1.3.1 Global Hepatitis A Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hepatitis A Vaccine Revenue 2021–2032
1.4.2 Global Hepatitis A Vaccine Sales 2021–2032
1.4.3 Global Hepatitis A Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hepatitis A Vaccine Market Competition by Manufacturers
2.1 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hepatitis A Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hepatitis A Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hepatitis A Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hepatitis A Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Hepatitis A Vaccine, Date of Entry into the Industry
2.8 Global Hepatitis A Vaccine Market Competitive Situation and Trends
2.8.1 Global Hepatitis A Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hepatitis A Vaccine Players Market Share by Revenue
2.8.3 Global Hepatitis A Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hepatitis A Vaccine Market Scenario by Region
3.1 Global Hepatitis A Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hepatitis A Vaccine Sales by Region: 2021–2032
3.2.1 Global Hepatitis A Vaccine Sales by Region: 2021–2026
3.2.2 Global Hepatitis A Vaccine Sales by Region: 2027–2032
3.3 Global Hepatitis A Vaccine Revenue by Region: 2021–2032
3.3.1 Global Hepatitis A Vaccine Revenue by Region: 2021–2026
3.3.2 Global Hepatitis A Vaccine Revenue by Region: 2027–2032
3.4 North America Hepatitis A Vaccine Market Facts & Figures by Country
3.4.1 North America Hepatitis A Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hepatitis A Vaccine Sales by Country (2021–2032)
3.4.3 North America Hepatitis A Vaccine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hepatitis A Vaccine Market Facts & Figures by Country
3.5.1 Europe Hepatitis A Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hepatitis A Vaccine Sales by Country (2021–2032)
3.5.3 Europe Hepatitis A Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Hepatitis A Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hepatitis A Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Hepatitis A Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hepatitis A Vaccine Market Facts & Figures by Country
3.7.1 Latin America Hepatitis A Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hepatitis A Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Hepatitis A Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis A Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hepatitis A Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hepatitis A Vaccine Sales by Type (2021–2032)
4.1.1 Global Hepatitis A Vaccine Sales by Type (2021–2026)
4.1.2 Global Hepatitis A Vaccine Sales by Type (2027–2032)
4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Hepatitis A Vaccine Revenue by Type (2021–2032)
4.2.1 Global Hepatitis A Vaccine Revenue by Type (2021–2026)
4.2.2 Global Hepatitis A Vaccine Revenue by Type (2027–2032)
4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Hepatitis A Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hepatitis A Vaccine Sales by Application (2021–2032)
5.1.1 Global Hepatitis A Vaccine Sales by Application (2021–2026)
5.1.2 Global Hepatitis A Vaccine Sales by Application (2027–2032)
5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Hepatitis A Vaccine Revenue by Application (2021–2032)
5.2.1 Global Hepatitis A Vaccine Revenue by Application (2021–2026)
5.2.2 Global Hepatitis A Vaccine Revenue by Application (2027–2032)
5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Hepatitis A Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GSK Hepatitis A Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Hepatitis A Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sinovac
6.4.1 Sinovac Company Information
6.4.2 Sinovac Description and Business Overview
6.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
6.4.5 Sinovac Recent Developments/Updates
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Company Information
6.5.2 Zhejiang Pukang Description and Business Overview
6.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
6.5.5 Zhejiang Pukang Recent Developments/Updates
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Company Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
6.6.5 Changchun Institute of Biological Recent Developments/Updates
6.7 KM Biologics
6.7.1 KM Biologics Company Information
6.7.2 KM Biologics Description and Business Overview
6.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 IMBCAMS
6.8.1 IMBCAMS Company Information
6.8.2 IMBCAMS Description and Business Overview
6.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 IMBCAMS Hepatitis A Vaccine Product Portfolio
6.8.5 IMBCAMS Recent Developments/Updates
6.9 Convac
6.9.1 Convac Company Information
6.9.2 Convac Description and Business Overview
6.9.3 Convac Hepatitis A Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Convac Hepatitis A Vaccine Product Portfolio
6.9.5 Convac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis A Vaccine Industry Chain Analysis
7.2 Hepatitis A Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis A Vaccine Production Mode & Process Analysis
7.4 Hepatitis A Vaccine Sales and Marketing
7.4.1 Hepatitis A Vaccine Sales Channels
7.4.2 Hepatitis A Vaccine Distributors
7.5 Hepatitis A Vaccine Customer Analysis
8 Hepatitis A Vaccine Market Dynamics
8.1 Hepatitis A Vaccine Industry Trends
8.2 Hepatitis A Vaccine Market Drivers
8.3 Hepatitis A Vaccine Market Challenges
8.4 Hepatitis A Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Convac
KM Biologics
Imbcams
List of Tables
 Table 1. Global Hepatitis A Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hepatitis A Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Hepatitis A Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Hepatitis A Vaccine Sales (K Unit) of Key Manufacturers (2021–2026)
 Table 5. Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Hepatitis A Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Hepatitis A Vaccine Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Hepatitis A Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Hepatitis A Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Hepatitis A Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Hepatitis A Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hepatitis A Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hepatitis A Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hepatitis A Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Hepatitis A Vaccine Sales by Region (K Unit), 2021–2026
 Table 18. Global Hepatitis A Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Hepatitis A Vaccine Sales by Region (K Unit), 2027–2032
 Table 20. Global Hepatitis A Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Hepatitis A Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Hepatitis A Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Hepatitis A Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Hepatitis A Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Hepatitis A Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Hepatitis A Vaccine Sales by Country (K Unit), 2021–2026
 Table 27. North America Hepatitis A Vaccine Sales by Country (K Unit), 2027–2032
 Table 28. North America Hepatitis A Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Hepatitis A Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Hepatitis A Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Hepatitis A Vaccine Sales by Country (K Unit), 2021–2026
 Table 32. Europe Hepatitis A Vaccine Sales by Country (K Unit), 2027–2032
 Table 33. Europe Hepatitis A Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Hepatitis A Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Hepatitis A Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Hepatitis A Vaccine Sales by Region (K Unit), 2021–2026
 Table 37. Asia Pacific Hepatitis A Vaccine Sales by Region (K Unit), 2027–2032
 Table 38. Asia Pacific Hepatitis A Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Hepatitis A Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Hepatitis A Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Hepatitis A Vaccine Sales by Country (K Unit), 2021–2026
 Table 42. Latin America Hepatitis A Vaccine Sales by Country (K Unit), 2027–2032
 Table 43. Latin America Hepatitis A Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Hepatitis A Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Hepatitis A Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Hepatitis A Vaccine Sales by Country (K Unit), 2021–2026
 Table 47. Middle East and Africa Hepatitis A Vaccine Sales by Country (K Unit), 2027–2032
 Table 48. Middle East and Africa Hepatitis A Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Hepatitis A Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Hepatitis A Vaccine Sales (K Unit) by Type (2021–2026)
 Table 51. Global Hepatitis A Vaccine Sales (K Unit) by Type (2027–2032)
 Table 52. Global Hepatitis A Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Hepatitis A Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Hepatitis A Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Hepatitis A Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Hepatitis A Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Hepatitis A Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Hepatitis A Vaccine Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Hepatitis A Vaccine Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Hepatitis A Vaccine Sales (K Unit) by Application (2021–2026)
 Table 61. Global Hepatitis A Vaccine Sales (K Unit) by Application (2027–2032)
 Table 62. Global Hepatitis A Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Hepatitis A Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Hepatitis A Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Hepatitis A Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Hepatitis A Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Hepatitis A Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Hepatitis A Vaccine Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Hepatitis A Vaccine Price (USD/Unit) by Application (2027–2032)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. GSK Hepatitis A Vaccine Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Merck Hepatitis A Vaccine Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Sanofi Hepatitis A Vaccine Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Sinovac Company Information
 Table 86. Sinovac Description and Business Overview
 Table 87. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Sinovac Hepatitis A Vaccine Product
 Table 89. Sinovac Recent Developments/Updates
 Table 90. Zhejiang Pukang Company Information
 Table 91. Zhejiang Pukang Description and Business Overview
 Table 92. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Zhejiang Pukang Hepatitis A Vaccine Product
 Table 94. Zhejiang Pukang Recent Developments/Updates
 Table 95. Changchun Institute of Biological Company Information
 Table 96. Changchun Institute of Biological Description and Business Overview
 Table 97. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Changchun Institute of Biological Hepatitis A Vaccine Product
 Table 99. Changchun Institute of Biological Recent Developments/Updates
 Table 100. KM Biologics Company Information
 Table 101. KM Biologics Description and Business Overview
 Table 102. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. KM Biologics Hepatitis A Vaccine Product
 Table 104. KM Biologics Recent Developments/Updates
 Table 105. IMBCAMS Company Information
 Table 106. IMBCAMS Description and Business Overview
 Table 107. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. IMBCAMS Hepatitis A Vaccine Product
 Table 109. IMBCAMS Recent Developments/Updates
 Table 110. Convac Company Information
 Table 111. Convac Description and Business Overview
 Table 112. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Convac Hepatitis A Vaccine Product
 Table 114. Convac Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Hepatitis A Vaccine Distributors List
 Table 118. Hepatitis A Vaccine Customers List
 Table 119. Hepatitis A Vaccine Market Trends
 Table 120. Hepatitis A Vaccine Market Drivers
 Table 121. Hepatitis A Vaccine Market Challenges
 Table 122. Hepatitis A Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hepatitis A Vaccine
 Figure 2. Global Hepatitis A Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hepatitis A Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Inactivated Vaccine Product Picture
 Figure 5. Live Attenuated Vaccine Product Picture
 Figure 6. Global Hepatitis A Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Hepatitis A Vaccine Market Share by Application: 2025 & 2032
 Figure 8. Government Institution
 Figure 9. Private Sector
 Figure 10. Other
 Figure 11. Global Hepatitis A Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Hepatitis A Vaccine Market Size (US$ Million), 2021–2032
 Figure 13. Global Hepatitis A Vaccine Sales (K Unit), 2021–2032
 Figure 14. Global Hepatitis A Vaccine Average Price (USD/Unit), 2021–2032
 Figure 15. Hepatitis A Vaccine Report Years Considered
 Figure 16. Hepatitis A Vaccine Sales Share by Manufacturers in 2025
 Figure 17. Global Hepatitis A Vaccine Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Hepatitis A Vaccine Players: Market Share by Revenue in Hepatitis A Vaccine in 2025
 Figure 19. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Hepatitis A Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Hepatitis A Vaccine Sales Market Share by Country (2021–2032)
 Figure 22. North America Hepatitis A Vaccine Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Hepatitis A Vaccine Sales Market Share by Country (2021–2032)
 Figure 26. Europe Hepatitis A Vaccine Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Region (2021–2032)
 Figure 34. China Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Hepatitis A Vaccine Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Hepatitis A Vaccine Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Hepatitis A Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Hepatitis A Vaccine by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Hepatitis A Vaccine by Type (2021–2032)
 Figure 56. Global Hepatitis A Vaccine Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Hepatitis A Vaccine by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Hepatitis A Vaccine by Application (2021–2032)
 Figure 59. Global Hepatitis A Vaccine Price (USD/Unit) by Application (2021–2032)
 Figure 60. Hepatitis A Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Hepatitis A Vaccination Market Research Report 2025
Mono Hepatitis A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inactivated Hepatitis A Vaccine Market Research Report 2024
Global Hepatitis A and B Vaccine Market Research Report 2025
Global Hepatitis A and B Vaccination Market Research Report 2025
Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis B Vaccination Market Research Report 2025
Hepatitis B Vaccines Market
Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A immunoglobulin Market Research Report 2025
Mono Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A Virus HAV Rapid Test Kit Market Research Report 2024
Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Preventable Vaccines Market Research Report 2024
Global Recombinant Hamster Ovary Cell CHO Hepatitis B Vaccine Market Insights Forecast to 2030
Global Travel Vaccines Market Insights Forecast to 2030
Global Adult and Pediatric Vaccines Market Research Report 2024
Global Human Injection Flu Vaccine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions